3//SEC Filing
PharmaNet Development Group Inc 3
Accession 0001209191-09-018864
CIK 0001089542operating
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 7:35 PM ET
Size
10.5 KB
Accession
0001209191-09-018864
Insider Transaction Report
Form 3
JLL PharmaNet Holdings, LLC
10% Owner
Holdings
- 19,794,475(indirect: By PDGI Holdco, Inc.)
Common Stock, par value $0.001 per share
JLL Partners Fund VI, L.P.
10% Owner
Holdings
- 19,794,475(indirect: By PDGI Holdco, Inc.)
Common Stock, par value $0.001 per share
JLL Associates VI, L.P.
10% Owner
Holdings
- 19,794,475(indirect: By PDGI Holdco, Inc.)
Common Stock, par value $0.001 per share
JLL Associates G.P. VI, L.L.C.
10% Owner
Holdings
- 19,794,475(indirect: By PDGI Holdco, Inc.)
Common Stock, par value $0.001 per share
Footnotes (2)
- [F1]The reporting persons disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that any of the reporting persons is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- [F2]JLL PharmaNet Holdings, LLC may be deemed to be the beneficial owner of 19,794,475 shares of common stock, par value $0.001 per share, of PharmaNet Development Group, Inc. held by PDGI Holdco, Inc. JLL Associates G.P. VI, L.L.C. is the general partner of JLL Associates VI, L.P., which in turn is the general partner of JLL Partners Fund VI, L.P. JLL Partners Fund VI, L.P. is a controlling member of JLL PharmaNet Holdings, LLC, the sole stockholder of PDGI Holdco, Inc. As a result, the reporting persons may be deemed to be the beneficial owner of the shares held by PDGI Holdco, Inc.
Documents
Issuer
PharmaNet Development Group Inc
CIK 0001089542
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001089542
Filing Metadata
- Form type
- 3
- Filed
- Mar 29, 8:00 PM ET
- Accepted
- Mar 30, 7:35 PM ET
- Size
- 10.5 KB